• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】18349

【品名】(E)-1,4-dibromo-2-butene;trans-1,4-dibromo-2-butene

【CA登记号】821-06-7

【 分 子 式 】C4H6Br2

【 分 子 量 】213.89964

【元素组成】C 22.46% H 2.83% Br 74.71%

与该中间体有关的原料药合成路线共 5 条

合成路线1

该中间体在本合成路线中的序号:(III)

Condensation of ethyl glycinate hydrochloride (I) with benzaldehyde in the presence of Na2SO4 and Et3N in tert-butyl methyl ether gives ethyl N-benzylideneglycinate (II), which is then cyclocondensed with trans-1,4-dibromo-2-butene (III) by means of t-BuOLi in toluene to yield ethyl 1-amino-2-vinylcyclopropanecarboxylate (IV). Alternatively, condensation of ethyl N-(diphenylmethylene)glycinate (V) also with trans-1,4-dibromo-2-butene (III) by means of t-BuOK in THF affords cyclopropanecarboxylate (IV), which is then N-protected with Boc2O at reflux to generate N-Boc derivative (VI). Enzymatic resolution of the racemate (VI) by means of acalase or savinase (proteases from Bacillus clausii) or esperase (protease from Bacillus halodurans) in DMSO at 40 °C leads to the desired ethyl (1R,2S)-N-Boc-cyclopropanecarboxylate diastereomer (VII). Hydrolysis of ethyl ester (VII) with LiOH in THF/MeOH leads to the carboxylic acid (VIII), which is then coupled with cyclopropanesulfonamide (IX) using CDI and DBU in THF to provide the sulfonamide (X). N-Deprotection of this compound by means of TFA in CH2Cl2 followed by treatment with HCl in Et2O gives amine hydrochloride (XI) .
Cyclopropanesulfonamide (IX) is prepared by amination of 3-chloropropane-1-sulfonyl chloride (XII) with t-BuNH2 in THF to provide N-tert-butyl-3-chloropropane-1-sulfonamide (XIII), which is then cyclocondensed in the presence of BuLi in THF to yield N-tert-butylcyclopropanesulfonamide (XIV). Finally, the tert-butyl group of intermediate (XIV) is removed with TFA, affording cyclopropanesulfonamide (IX), which can also be prepared by direct amination of cyclopropanesulfonyl chloride (XV) with NH3 in THF .

1 Campbell, J.A., Wang, X.A., Sin, N. et al. (Bristol-Myers Squibb Co.). Hepatitis C virus inhibitors. EP 1505963, EP 2340830, JP 2005533028, KR 2010093140, US 200410659, US 6995174, US 2011311482, WO 200309974.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(X) 68241 tert-butyl ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamate   C14H22N2O5S 详情 详情
(XV) 67915 cyclopropanesulfonyl chloride;Cyclopropylsulfonylchloride;Cyclopropylsulphonyl chloride 139631-62-2 C3H5ClO2S 详情 详情
(I) 68234 ethyl glycinate hydrochloride;Glycine ethyl ester hydrochloride 623-33-6 C4H9NO2.HCl 详情 详情
(II) 68235 (E)-ethyl 2-(benzylideneamino)acetate;2-(benzylideneamino)acetic acid ethyl ester;ethyl N-benzylideneglycinate;Benzylideneglycine ethyl ester;N-Benzylideneglycineethyl ester;ethyl(benzylideneamino)acetate 40682-54-0 C11H13NO2 详情 详情
(III) 18349 (E)-1,4-dibromo-2-butene;trans-1,4-dibromo-2-butene 821-06-7 C4H6Br2 详情 详情
(IV) 68236 ethyl 1-amino-2-vinylcyclopropanecarboxylate 787548-29-2 C8H13NO2 详情 详情
(V) 68237 ethyl N-(diphenylmethylene)glycinate;(Benzhydrylideneamino)aceticacid methyl ester;Benzophenoneimine glycine methyl ester;Methyl2-[(diphenylmethylene)amino]acetate;Methyl 3-aza-4,4-diphenylbut-3-enoate;Methyl N-(diphenylmethylene)glycinate;Methyl[(diphenylmethylene)amino]acetate;N-(Diphenylmethylene)glycine methyl ester;N-Diphenylmethylideneglycine methyl ester 81167-39-7 C16H15NO2 详情 详情
(VI) 68238 ethyl 1-((tert-butoxycarbonyl)amino)-2-vinylcyclopropanecarboxylate 681807-59-0 C13H21NO4 详情 详情
(VII) 68239 ethyl (1R,2S)-1-((tert-butoxycarbonyl)amino)-2-vinylcyclopropanecarboxylate 213316-49-5 C13H21NO4 详情 详情
(VIII) 68240 (1R,2S)-1-((tert-butoxycarbonyl)amino)-2-vinylcyclopropanecarboxylic acid 213316-50-8 C11H17NO4 详情 详情
(IX) 68242 cyclopropanesulfonamide;Cyclopropanesulfonyl amide 154350-29-5 C3H7NO2S 详情 详情
(XI) 68243 tert-butyl ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamate hydrochloride   C14H22N2O5S.HCl 详情 详情
(XII) 39225 g-Chloropropanesulfonyl chloride;3-Chloropropansulfonyl chloride;1-Chloro-3-propanesulfonylchloride;3-Chloropropanesulfonyl chloride;3-chloro-1-propanesulfonyl chloride;3-chloropropane-1-sulfonyl chloride 1633-82-5 C3H6Cl2O2S 详情 详情
(XIII) 68244 N-tert-butyl-(3-chloro)propylsulfonamide;N-tert-butyl-3-chloropropane-1-sulfonamide;3-Chloro-N-(1,1-dimethylethyl)-1-propanesulfonamide;1-Propanesulfonamide,3-chloro-N-(1,1-dimethylethyl)- 63132-85-4 C7H16ClNO2S 详情 详情
(XIV) 68245 N-(tert-butyl)cyclopropanesulfonamide;N-tert-butylcyclopropanesulfonamide;N-(tert-butyl)cyclopropanesulfonamide   C7H15NO2S 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XXIX)

Condensation of benzaldehyde (XXVI) with ethyl glycinate hydrochloride (XXVII) by means of Na2SO4 and Et3N in tert-butyl methyl ether gives 2-(benzylideneamino)acetic acid ethyl ester (XXVIII), which cyclizes with 1,4-dibromo-2(E)-butene (XXIX) in the presence of t-BuOLi in dry toluene to yield, after imine hydrolysis, the cyclopropylamine derivative (XXX). Protection of amine (XXX) with Boc2O furnishes the racemic N-Boc amino ester (XXXI), which is subjected to kinetic resolution by means of enzymes such as Acalase®, Savinase® or Esperase® in DMSO to afford unreacted (1R,2S)-isomer (XXXII). Saponification of ethyl ester (XXXII) using LiOH in THF/MeOH gives the cyclopropanecarboxylic acid derivative (XXXIII), which, after activation with CDI in refluxing THF, is coupled with cyclopropanesulfonamide (XXXIV) (prepared by treatment of cyclopropanesulfonyl chloride [XXXV] with NH3 in THF) in the presence of DBU to yield the N-acylsulfonamide (XXXVI). Alternatively, the sulfonamide intermediate (XXXIV) can be prepared by condensation of 3-chloropropanesulfonyl chloride (XXXVIII) with tert-butylamine in THF to give N-tert-butyl-(3-chloro)propylsulfonamide (XXXIX), which then cyclizes to the cyclopropyl derivative (XL) by treatment with n-BuLi in THF at –78 °C. Removal of the N-tert-butyl group in intermediate (XL) using CF3CO2H then furnishes cyclopropanesulfonamide (XXXIV). After N-Boc group cleavage in (XXXVI) by means of CF3CO2H in DCM, acidification with HCl in Et2O affords intermediate (IV) . Intermediate (VIII) can be obtained by vinyl group reduction in (IV) with H2 and Pd/C in EtOAc. Intermediate (VIII) can also be obtained by reduction of vinylcyclopropylamine derivative (XXXVI) with H2 over Ru/C in MeOH to yield N-Boc-ethylcyclopropylamine (XXXVII), which is finally N-deprotected by means of HCl in CH2Cl2 .

1 Sun, L.-Q., Sit, S.-Y., Scola, P.M. et al. (Bristol-Myers Squibb Co.). Hepatitis C virus inhibitors. EP 1505963, JP 2005533028, US 2004106559, US 6995174, WO 2003099274.
2 Holloway, M.K., Liverton, N.J., McCauley, J.A., Rudd, M.T., Vacca, J.P., Ludmerer, S.W., Olsen, D.B. (Merck & Co., Inc.). Macrocyclic peptides as HCV NS3 protease inhibitors. EP 1913016, JP 2009503080, WO 200701641.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV) 69058 (1S,2R)-1-amino-N-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxamide hydrochloride   C9H14N2O3S.HCl 详情 详情
(VIII) 69059 (1S,2S)-1-amino-N-(cyclopropylsulfonyl)-2-ethylcyclopropanecarboxamide hydrochloride   C9H16N2O3S.HCl 详情 详情
(XXVI) 10498 Benzaldehyde;Benzoic aldehyde;Phenylmethanal 100-52-7 C7H6O 详情 详情
(XXVII) 67884 methyl glycinate hydrochloride 5680-79-5 C3H7NO2.HCl 详情 详情
(XXVIII) 68235 (E)-ethyl 2-(benzylideneamino)acetate;2-(benzylideneamino)acetic acid ethyl ester;ethyl N-benzylideneglycinate;Benzylideneglycine ethyl ester;N-Benzylideneglycineethyl ester;ethyl(benzylideneamino)acetate 40682-54-0 C11H13NO2 详情 详情
(XXIX) 18349 (E)-1,4-dibromo-2-butene;trans-1,4-dibromo-2-butene 821-06-7 C4H6Br2 详情 详情
(XXX) 68236 ethyl 1-amino-2-vinylcyclopropanecarboxylate 787548-29-2 C8H13NO2 详情 详情
(XXXI) 68238 ethyl 1-((tert-butoxycarbonyl)amino)-2-vinylcyclopropanecarboxylate 681807-59-0 C13H21NO4 详情 详情
(XXXII) 69076 (1R,2R)-ethyl 1-((tert-butoxycarbonyl)amino)-2-vinylcyclopropanecarboxylate   C13H21NO4 详情 详情
(XXXIII) 69077 (1R,2R)-1-((tert-butoxycarbonyl)amino)-2-vinylcyclopropanecarboxylic acid   C11H17NO4 详情 详情
(XXXIV) 68242 cyclopropanesulfonamide;Cyclopropanesulfonyl amide 154350-29-5 C3H7NO2S 详情 详情
(XXXV) 67915 cyclopropanesulfonyl chloride;Cyclopropylsulfonylchloride;Cyclopropylsulphonyl chloride 139631-62-2 C3H5ClO2S 详情 详情
(XXXVI) 69078 tert-butyl ((1R,2R)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamate   C14H22N2O5S 详情 详情
(XXXVII) 69079 tert-butyl ((1R,2R)-1-((cyclopropylsulfonyl)carbamoyl)-2-ethylcyclopropyl)carbamate   C14H24N2O5S 详情 详情
(XXXVIII) 39225 g-Chloropropanesulfonyl chloride;3-Chloropropansulfonyl chloride;1-Chloro-3-propanesulfonylchloride;3-Chloropropanesulfonyl chloride;3-chloro-1-propanesulfonyl chloride;3-chloropropane-1-sulfonyl chloride 1633-82-5 C3H6Cl2O2S 详情 详情
(XXXIX) 68244 N-tert-butyl-(3-chloro)propylsulfonamide;N-tert-butyl-3-chloropropane-1-sulfonamide;3-Chloro-N-(1,1-dimethylethyl)-1-propanesulfonamide;1-Propanesulfonamide,3-chloro-N-(1,1-dimethylethyl)- 63132-85-4 C7H16ClNO2S 详情 详情
(XL) 68245 N-(tert-butyl)cyclopropanesulfonamide;N-tert-butylcyclopropanesulfonamide;N-(tert-butyl)cyclopropanesulfonamide   C7H15NO2S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

Substitution on dibromobutene (I) by potassium phthalimide (II) provided bromobutenyl phthalimide (III). Further treatment with sodium acetate afforded acetate (IV) which, after hydrolysis, gave phthalimidobutenol (V). Reaction with refluxing ethyl orthoacetate in the presence of a trace of butyric acid generated the intermediate ketene acetal (VI), which experienced a Claisen rearrangement to give pentenoate ester (VII). Ozonolysis of the olefinic double bond of (VII) yielded aldehyde (VIII). Then, Wittig reaction of aldehyde (VIII) with (isopropylidene)triphenylphosphorane in cold THF provided olefin (IX), which was hydrogenated in the presence of Pd/C to give the isobutyl compound (X). Finally, hydrolysis of both ester and phthalimide groups in refluxing 6 N HCl provided the GABA analogue.

1 Serfass, L.; Casara, P.J.; General synthesis of 3-substituted alkenyl GABA as potential anticonvulsants. Bioorg Med Chem Lett 1998, 8, 18, 2599.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18349 (E)-1,4-dibromo-2-butene;trans-1,4-dibromo-2-butene 821-06-7 C4H6Br2 详情 详情
(II) 10926 (1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium C8H4KNO2 详情 详情
(III) 18351 2-[(E)-4-bromo-2-butenyl]-1H-isoindole-1,3(2H)-dione C12H10BrNO2 详情 详情
(IV) 18352 (E)-4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-2-butenyl acetate C14H13NO4 详情 详情
(V) 18353 2-[(E)-4-hydroxy-2-butenyl]-1H-isoindole-1,3(2H)-dione C12H11NO3 详情 详情
(VI) 18354 2-[(E)-4-[(1-ethoxyvinyl)oxy]-2-butenyl]-1H-isoindole-1,3(2H)-dione C16H17NO4 详情 详情
(VII) 18355 ethyl 3-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-4-pentenoate C16H17NO4 详情 详情
(VIII) 18356 ethyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-formylbutanoate C15H15NO5 详情 详情
(IX) 18357 ethyl 3-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-5-methyl-4-hexenoate C18H21NO4 详情 详情
(X) 18358 ethyl 3-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-5-methylhexanoate C18H23NO4 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

The intermediate phenylacetic acid allyl ester (IV) is prepared by two methods. Reaction of trans-1,4-dibromo-2-butene (I) with benzyl alcohol under phase-transfer conditions provides the benzyl ether (II). Subsequent DBU-mediated coupling of (II) with (4-methoxyphenyl)acetic acid (III) yields ester (IV).

1 Kottirsch, G.; et al.; beta-Aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme. J Med Chem 2002, 45, 11, 2289.
2 Kottirsch, G.; Neumann, U. (Novartis AG); Hydroxamic acid derivs.. EP 0929517; JP 2000508338; US 2002003804; US 6500983; WO 9814424 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18349 (E)-1,4-dibromo-2-butene;trans-1,4-dibromo-2-butene 821-06-7 C4H6Br2 详情 详情
(II) 61680 benzyl (E)-4-bromo-2-butenyl ether; 1-({[(E)-4-bromo-2-butenyl]oxy}methyl)benzene C11H13BrO 详情 详情
(III) 34794 (E)-3-chloro-2,3-bis(4-methoxyphenyl)-2-propenal C17H15ClO3 详情 详情
(IV) 61681 (E)-4-(benzyloxy)-2-butenyl 2-(4-methoxyphenyl)acetate C20H22O4 详情 详情

合成路线5

该中间体在本合成路线中的序号:(XXV)

Condensation of benzaldehyde (XXII) with ethyl glycinate hydrochloride (XXIII) in the presence of Na2SO4 and Et3N in tert-butyl methyl ether gives ethyl[(benzylidene)amino]acetate (XXIV), which upon reaction with 1,4-dibromo-2-butene (XXV) in the presence of t-BuOLi in toluene yields racemic ethyl 1-amino-2-vinylcyclopropanecarboxylate (rac-[XXVI]). Resolution of rac-(XXVI) by treatment with (+)-dibenzoyltartaric acid in EtOAc gives ethyl 1(R)-amino-2(S)-vinylcyclopropanecarboxylate (+)-dibenzoyltartrate (XXVII) salt, which is finally treated with HCl in Et2O .
Alternatively, amino ester (rac-[XXVI]) can be prepared by condensation of ethyl ester (XXVIII) with 1,4-dibromo-2-butene (XXV) in the presence of t-BuOK in THF, followed by treatment of the resulting imine (rac-[XXIX]) with HCl in Et2O and then with NaHCO3 .

1 Llinas-Brunet, M., Bailey, M.D., Cameron, D. et al. (Boehringer Ingelheim [Canada] Ltd.). Hepatitis C inhibitor tri-peptides. CA 2338946, EP 1105413, EP 2028186, JP 2002522554, US 6323180, WO 2000009543.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
rac-(XXVI) 69285 racemic ethyl 1-amino-2-vinylcyclopropanecarboxylate   C8H13NO2 详情 详情
rac-(XXIX) 69287 racemic ethyl 1-((diphenylmethylene)amino)-2-vinylcyclopropanecarboxylate   C21H21NO2 详情 详情
(IX) 69270 (1R,2S)-ethyl 1-amino-2-vinylcyclopropanecarboxylate 746657-36-3 C8H13NO2 详情 详情
(XXII) 10498 Benzaldehyde;Benzoic aldehyde;Phenylmethanal 100-52-7 C7H6O 详情 详情
(XXIII) 68234 ethyl glycinate hydrochloride;Glycine ethyl ester hydrochloride 623-33-6 C4H9NO2.HCl 详情 详情
(XXIV) 68235 (E)-ethyl 2-(benzylideneamino)acetate;2-(benzylideneamino)acetic acid ethyl ester;ethyl N-benzylideneglycinate;Benzylideneglycine ethyl ester;N-Benzylideneglycineethyl ester;ethyl(benzylideneamino)acetate 40682-54-0 C11H13NO2 详情 详情
(XXV) 18349 (E)-1,4-dibromo-2-butene;trans-1,4-dibromo-2-butene 821-06-7 C4H6Br2 详情 详情
(XXVII) 69286 ethyl 1(R)-amino-2(S)-vinylcyclopropanecarboxylate (+)-dibenzoyltartrate 213316-32-6 C8H13NO2 详情 详情
(XXVIII) 26772 ethyl 2-((diphenylmethylene)amino)acetate;N-(Diphenylmethylene)glycine ethyl ester;Ethyl N-(diphenylmethylene)glycinate;ethyl 2-[(dibenzylene)amino]acetate 69555-14-2 C17H17NO2 详情 详情
Extended Information